Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219134 · ClinicalTrials.gov registry record
Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System
A clinical trial of Genitourinary System Carcinoma and Malignant Pelvic Neoplasm, sponsored by University of Michigan Rogel Cancer Center.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT07219134 is a study of Genitourinary System Carcinoma and Malignant Pelvic Neoplasm that is actively recruiting participants, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 30 participants, below the 2,399-participant average among 3 other Genitourinary System Carcinoma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07219134, a study of Genitourinary System Carcinoma and Malignant Pelvic Neoplasm, is actively recruiting participants, sponsored by University of Michigan Rogel Cancer Center.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to see if researchers can find a better way to image a patient's tumor during radiation treatment.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Michigan
- University of Michigan Comprehensive Cancer Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-06-06 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07219134
The ClinicalTrials.gov registry entry for NCT07219134 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,399-participant average among 3 other Genitourinary System Carcinoma trials with a reported enrollment target (99% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Genitourinary System Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07219134 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT07219134 about?
NCT07219134 is a clinical study titled "Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System". This study is being done to see if researchers can find a better way to image a patient's tumor during radiation treatment.
What is the current status of trial NCT07219134?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-06-06. Estimated completion is 2027-06.
What conditions does trial NCT07219134 study?
This clinical trial studies the following conditions: Genitourinary System Carcinoma, Malignant Pelvic Neoplasm.
What interventions are being tested in trial NCT07219134?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07219134?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219134 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genitourinary System Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
RECRUITING
-
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.